Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (19 items missing)
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Transformation
22
0
20
Platform and operations
4
0
77
Total revenue
26
0
97
Cost of revenues (exclusive of depreciation and amortization presented below)
30
0
57
Selling, general and administrative expenses
16
0
75
Depreciation and amortization expenses
1
0
7
Total operating expenses
47
0
140
Operating income (loss)
-21
0
-43
Interest Income (Expense), Net
-1
0
0
Gain on consolidation
0
0
414
Gain on deconsolidation
46
0
0
Income (loss) from affiliate
-4
-25
-28
Other income (expense), net
0
0
0
Income (loss) before income taxes and non-controlling interests
20
-25
343
Provision (benefit) for income taxes
0
0
23
Net Income (Loss)
20
-25
320
Net income (loss) attributable to non-controlling interests
0
0
-13
Net income (loss) attributable to Evolent Health, Inc.
20
-25
332
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (32 items missing)
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
0
146
Restricted cash
n/a
0
5
Accounts receivable, net
n/a
0
20
Prepaid expenses and other current assets
n/a
0
4
Investments, at amortized cost
n/a
0
9
Total current assets
n/a
0
184
Restricted cash
n/a
0
2
Investments, at amortized cost
n/a
0
45
Property and equipment, net
n/a
0
13
Intangible assets, net
n/a
0
163
Other non-current assets
n/a
0
0
Goodwill
n/a
0
609
Equity method investment
n/a
37
0
Total assets
n/a
37
1,016
Liabilities and owners' equity
Accounts payable
n/a
0 0
17 16699000
Accrued liabilities
n/a
0 0
6 6047000
Accrued compensation and employee benefits
n/a
0 0
22 21925000
Deferred revenue
n/a
0 0
15 14835000
Total current liabilities
n/a
0 0
60 59506000
Other long-term liabilities
n/a
0 0
0 111000
Deferred tax liabilities, net
n/a
0 0
21 21318000
Total liabilities
n/a
0 0
81 80935000
Commitments and contingencies
n/a
0 0
0 0
Redeemable preferred stock, value
n/a
39 39273000
0 0
Additional paid-in-capital
n/a
24 23733000
342 342063000
Retained earnings (accumulated deficit)
n/a
-26 -25806000
307 306688000
Total shareholders' equity (deficit) attributable to Evolent Health, Inc.
n/a
-2 -2070000
649 649341000
Non-controlling interests
n/a
0 0
285 285238000
Total equity (deficit)
n/a
-2 -2070000
935 934579000
Total liabilities, redeemable preferred stock and shareholders' equity (deficit)
n/a
37 37203000
1,016 1015514000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (32 items missing)
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Net Income (Loss)
20
-25
320
Gain on consolidation
0
0
-414
Gain on deconsolidation
-46
0
0
Loss from equity method investees
4
25
28
Depreciation and amortization expenses
1
0
7
Stock-based compensation expense
0
0
15
Deferred tax provision
0
0
23
Other
1
0
0
Accounts receivables, net
-9
0
12
Prepaid expenses and other current assets
-2
0
-2
Accounts payable
-1
0
3
Accrued liabilities
1
0
-4
Accrued compensation and employee benefits
4
0
11
Deferred revenue
9
0
-18
Other long-term liabilities
4
0
0
Net cash provided by (used in) operating activities
-14
0
-18
Cash acquired upon consolidation of affiliate
0
0
13
Cash transferred upon deconsolidation of affiliate
-16
0
0
Purchases of investments
0
0
-54
Maturities and sales of investments
0
0
4
Purchases of property and equipment
-10
0
-7
Change in restricted cash
0
0
0
Net cash provided by (used in) investing activities
-26
0
-44
Proceeds from initial public offering, net of offering costs
0
0
209
Proceeds from stock option exercises
0
0
0
Proceeds from issuance of convertible notes
23
0
0
Payments of deferred offering costs
0
0
-1
Net cash provided by (used in) financing activities
34
0
208
Net increase (decrease) in cash and cash equivalents
-5
0
146
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,